13F filer · CIK 315066 ↗
Fidelity Investments
You are looking at Q2 2023. See the latest, Q2 2026 →
Reported value
$1.19T
−45% on the quarter before
Positions
5,364
522 new · 414 sold out
Top 10
29.7%
of the value
Est. gain
+$103.27B
on stocks held all quarter
Est. return
+9.6%
on those stocks since Q1 2023
Positions as of Jun 30, 2023, from Fidelity Investments's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 39% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2023. Striped tiles are options.
Largest buys
Since Q1 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Canadian Pacific Kansas City~$2.46BNew · 0.0% → 0.2%+30,448,702 shares
- Thomson Reuters Corp.~$604.6MNew · 0.0% → 0.1%+4,478,089 shares
- Crane Company~$588.6MNew · 0.0% → 0.0%+6,604,359 shares
- Transunion~$395.1MAdded · 0.0% → 0.0%+5,043,503 shares
- Vulcan Matls Co~$364.2MAdded · 0.0% → 0.1%+1,615,375 shares
- Kenvue Inc~$350.6MNew · 0.0% → 0.0%+13,269,873 shares
- Invesco Exch Traded Fd Tr Ii~$341.6MAdded · 0.0% → 0.1%+2,247,989 shares
- Ares Management~$302.4MAdded · 0.0% → 0.0%+3,138,294 shares
- Privia Health Group Inc~$297.1MAdded · 0.0% → 0.0%+11,377,759 shares
- Ishares Tr~$289.6MAdded · 0.0% → 0.0%+2,677,594 shares
Largest sells
Since Q1 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Microsoft~$65.02BCut · 5.3% → 6.0%−190,935,496 shares
- Apple~$61.26BCut · 4.7% → 5.0%−315,808,514 shares
- Nvidia~$59.79BCut · 3.5% → 4.7%−141,343,443 shares
- Amazon~$35.75BCut · 2.6% → 3.1%−274,263,272 shares
- Meta~$33.98BCut · 2.4% → 3.0%−118,412,031 shares
- Alphabet~$23.99BCut · 2.0% → 2.2%−200,410,580 shares
- Unitedhealth Group Inc~$22.15BCut · 2.0% → 1.8%−46,088,745 shares
- Exxon Mobil Corp~$15.97BCut · 1.5% → 1.3%−148,861,516 shares
- Berkshire Hathaway Inc Del~$15.78BCut · 1.4% → 1.5%−30,473 shares
- Eli Lilly~$14.64BCut · 1.0% → 1.3%−31,216,263 shares
Holdings
As of Jun 30, 2023. Changes are in shares against Mar 31, 2023, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −48% · price +18.1% | 6.0% | $71.55B | +$10.98B | ||||||||
| AppleCOM · shares −51% · price +17.6% | 5.0% | $59.56B | +$8.93B | ||||||||
| NvidiaCOM · shares −52% · price +52.3% | 4.7% | $55.62B | +$19.10B | ||||||||
| AmazonCOM · shares −49% · price +26.2% | 3.1% | $36.56B | +$7.59B | ||||||||
| MetaCL A · shares −48% · price +35.4% | 3.0% | $36.10B | +$9.44B | ||||||||
| AlphabetCAP STK CL A · shares −48% · price +15.4% | 2.2% | $25.77B | +$3.44B | ||||||||
| Unitedhealth Group IncCOM · shares −51% · price +1.7% | 1.8% | $21.60B | +$361.8M | ||||||||
| Berkshire Hathaway Inc DelCL A · shares −48% · price +11.2% | 1.5% | $17.33B | +$1.75B | ||||||||
| Eli LillyCOM · shares −49% · price +36.6% | 1.3% | $15.38B | +$4.12B | ||||||||
| Exxon Mobil CorpCOM · shares −51% · price −2.2% | 1.3% | $15.13B | −$339.9M | ||||||||
| AlphabetCAP STK CL C · shares −45% · price +16.3% | 1.2% | $14.02B | +$1.97B | ||||||||
| Visa Inc.COM CL A · shares −50% · price +5.3% | 0.96% | $11.42B | +$578.2M | ||||||||
| NetflixCOM · shares −50% · price +27.5% | 0.87% | $10.37B | +$2.24B | ||||||||
| MastercardCL A · shares −55% · price +8.2% | 0.70% | $8.31B | +$631.2M | ||||||||
| SalesforceCOM · shares −48% · price +5.7% | 0.67% | $8.00B | +$434.8M | ||||||||
| Marvell Technology IncCOM · shares −50% · price +38.1% | 0.65% | $7.71B | +$2.13B | ||||||||
| TeslaCOM · shares −57% · price +26.2% | 0.63% | $7.53B | +$1.56B | ||||||||
| Wells Fargo Co NewCOM · shares −54% · price +14.2% | 0.63% | $7.52B | +$934.4M | ||||||||
| Jpmorgan Chase & CoCOM · shares −42% · price +11.6% | 0.60% | $7.10B | +$738.5M | ||||||||
| General Electric CoCOM NEW · shares −50% · price +14.9% | 0.59% | $7.05B | +$914.1M | ||||||||
| Lululemon Athletica IncCOM · shares −50% · price +3.9% | 0.58% | $6.94B | +$262.3M | ||||||||
| Regeneron PharmaceuticalsCOM · shares −51% · price −12.6% | 0.55% | $6.59B | −$945.8M | ||||||||
| Boston Scientific CorpCOM · shares −48% · price +8.1% | 0.53% | $6.38B | +$478.6M | ||||||||
| UberCOM · shares −46% · price +36.2% | 0.52% | $6.22B | +$1.65B | ||||||||
| Bank America CorpCOM · shares −56% · price +0.3% | 0.50% | $5.92B | +$18.6M | ||||||||
| Total · 5,364 positions | 100% | $1.19T | +$103.27B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2023 to Q2 2023: 4,652 stocks held throughout, up $103.27B (+9.6%).
- Nvidia+$19.10B+52%
- Microsoft+$10.98B+18%
- Meta+$9.44B+35%
- Apple+$8.93B+18%
- Amazon+$7.59B+26%
- Crane Nxt Co−$415.8M−50%
- Sea−$467.1M−33%
- Thermo Fisher Scientific Inc−$503.1M−9%
- Churchill Downs Inc−$793.7M−46%
- Regeneron Pharmaceuticals−$945.8M−13%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 43 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $2.30T+21% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.90T−3% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $1.96T+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $1.92T+8% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $1.77T+13% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.57T−7% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $1.68T+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $1.64T+5% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $1.56T+5% | SEC ↗ |
| Q1 2024 | May 13, 2024 | $1.49T+14% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $1.30T+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $1.16T−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $1.19T−45% | SEC ↗ |
| Q1 2023 | May 11, 2023 (amended) | $2.19T+117% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $1.01T+5% | SEC ↗ |
| Q3 2022 | Nov 10, 2022 | $958.93B−4% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $1.00T−20% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $1.25T−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $1.35T+7% | SEC ↗ |
| Q3 2021 | Feb 14, 2022 (amended) | $1.26T−1% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $1.28T+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $1.17T+4% | SEC ↗ |
| Q4 2020 | Feb 8, 2021 | $1.12T+14% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $989.33B+9% | SEC ↗ |
| Q2 2020 | Aug 24, 2020 (amended) | $909.48B+26% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $722.13B−20% | SEC ↗ |
| Q4 2019 | Feb 7, 2020 | $906.40B+9% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $833.77B−3% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $856.19B+3% | SEC ↗ |
| Q1 2019 | May 13, 2019 (amended) | $834.93B+14% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 (amended) | $730.25B−18% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $888.88B+2% | SEC ↗ |
| Q2 2018 | Aug 10, 2018 (amended) | $868.68B+3% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $842.35B−1% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $853.06B+3% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $827.12B+3% | SEC ↗ |
| Q2 2017 | Aug 29, 2017 (amended) | $804.55B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $787.10B+5% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 (amended) | $748.25B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $750.86B+2% | SEC ↗ |
| Q2 2016 | Aug 11, 2016 | $732.58B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $722.80B | SEC ↗ |